JPH0456592B2 - - Google Patents
Info
- Publication number
- JPH0456592B2 JPH0456592B2 JP9210585A JP9210585A JPH0456592B2 JP H0456592 B2 JPH0456592 B2 JP H0456592B2 JP 9210585 A JP9210585 A JP 9210585A JP 9210585 A JP9210585 A JP 9210585A JP H0456592 B2 JPH0456592 B2 JP H0456592B2
- Authority
- JP
- Japan
- Prior art keywords
- immobilized
- aqueous solution
- fibroin
- film
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000007864 aqueous solution Substances 0.000 claims description 25
- 244000005700 microbiome Species 0.000 claims description 25
- 108010022355 Fibroins Proteins 0.000 claims description 24
- 238000004519 manufacturing process Methods 0.000 claims description 13
- 238000010008 shearing Methods 0.000 claims description 10
- 238000000465 moulding Methods 0.000 claims description 7
- 239000013078 crystal Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000005345 coagulation Methods 0.000 claims description 2
- 230000015271 coagulation Effects 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 30
- 239000010408 film Substances 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 15
- 239000012528 membrane Substances 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 238000003756 stirring Methods 0.000 description 12
- 230000000813 microbial effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- -1 etc. Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 3
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229930016911 cinnamic acid Natural products 0.000 description 3
- 235000013985 cinnamic acid Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 241001156739 Actinobacteria <phylum> Species 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108010013296 Sericins Proteins 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229960005190 phenylalanine Drugs 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 241000590020 Achromobacter Species 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 229910013553 LiNO Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000223253 Rhodotorula glutinis Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- AQEDFGUKQJUMBV-UHFFFAOYSA-N copper;ethane-1,2-diamine Chemical compound [Cu].NCCN AQEDFGUKQJUMBV-UHFFFAOYSA-N 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000002218 isotachophoresis Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
(産業上の利用分野)
本発明は固定化微生物の製造方法に関する。
(従来の技術)
微生物の化合物変換や生産能を利用し、有用な
化合物を生産することが、近年益々盛んになつて
いる。又、これを反復使用可能な形とし、且つ生
産物と微生物菌体とを容易に分離するため、微生
物を固定化して用いる研究が活発に行われてお
り、種々の方法が知られている。
従来、微生物の固定化方法としては、微生物が
酸素や抗体といつた蛋白質分子に比較し、はるか
に大きな形を有するものである為、アクリルアミ
ドポリマー、ヒドロキシエチルメタクリレートポ
リマー等の合成ポリマーや、アルギン酸、カラギ
ーナン等の天然ポリマーゲルによる包括固定化が
有利であると謂われている。しかし、ポリアクリ
ルアミドゲル等の合成ポリマーを用いる方法の場
合、モノマーの毒性の為、微生物が死滅したり、
菌体内酵素の失活等が起こり易い。又、開始剤や
光重合架橋法で用いる増感剤が菌体に損失を与え
たり、この固定化微生物を用いて食品や医薬品等
の製造を行う場合、生産物にこれ等が混入する等
の問題がある。
更に、これ等の架橋性樹脂の多くは、脆く、膜
状等に成型した場合、折れたり、砕けたりする欠
陥がある。天然物ポリマーゲル、即ち、アルギン
酸のカルシウムイオン架橋ゲルや、カラギーナン
のカリウムイオンによるゲルで固定化する方法
は、安全な天然物による温和な方法であるが、使
用条件によつて、経時的に架橋が切断され解膠し
て菌体等の漏出が起こる問題がある。
又、これ等の方法によつて得られるものは、所
謂、拡散律速型の固定化物となる為、これを薄膜
として用いる事が有利であるが、その為に十分な
強度を有するとは言い難い。
(発明が解決しようとする問題点)
本発明者等は、前述の諸欠点を改良し、効率良
く、且つ安定性に優れると共に、十分な強度を有
する微生物の固定化法に就いて、鋭意研究の結
果、本発明を完成したものである。
本発明の目的は、微生物菌体に損傷を与えるこ
となく、高活性を保持したまま或いは死滅するこ
となく固定化する事が可能であると共に、経時的
な脱落がない安定な微生物の固定化方法を提供す
るにある。他の目的は、上記特長を有し更に、膜
強度の物理的性質に優れ、可撓性を有し、且つ、
拡散律速の影響を受けにくい固定化微生物膜の製
造方法を提供するにある。
(問題点を解決するための手段)
上述の目的は、剪断力を作用し、結晶域を配向
せしめたフイブロインと、微生物菌体とを分散し
た水溶液を、水溶液中へのフイブロインの析出、
或いは水溶液の凝固が起こる前に、成型工程に付
すことを特徴とする固定化微生物の製造方法によ
り達成される。
上記本発明方法に於いて微生物とフイブロイン
を含有する水溶液は種々の方法で調整されるが好
ましい調整方法の一例を示すと次の通りである。
生糸、まゆ、生糸屑、キキ、ビス、ブーレツト
等の絹原料を常法に従い、セリシンを精練除去し
たものを、フイブロインを溶解し得る例えばアル
カリ金属塩又はアルカリ土類金属塩の水溶液ある
いは銅−エチレンジアミン水溶液等に溶解せし
め、更にそれを透析脱塩し、フイブロインの濃度
を通常1〜20重量%、好ましくは5〜15重量%に
調整し、予めフイブロイン水溶液を調整してお
く。
上記のアルカリ金属塩及びアルカリ土類金属塩
としては、LiCl、LiBr、Nal、LiNO3、MgCl2、
MgBr2、Mg(NO3)2ZnCl2、Zn(NO3)2等が使用
されるが、溶解性並びにフイブロインの分子量を
出来る限り高く保つためにCaCl2又はCa(NO3)2
の使用が好ましい。
また、該金属塩濃度は5〜80重量%、好ましく
は20〜70重量%、特に好ましくは40〜60重量%で
ある。又溶解性をより一層ならしめる為に、該水
溶液にメチルアルコール、エチルアルコール、プ
ロピルアルコール等のアルコール類の添加が好ま
しい。添加時期は、絹の溶解の前又は途中が良
く、又添加量は該金属塩溶液に対し、20〜60重量
%、好ましくは25〜50重量%である。
本発明で固定化する微生物菌体は、酵母、細
菌、放射菌等が適宜用いられ例えば、アクロモバ
クター属、フラボバクテリウム属、エスシエリシ
ア属、アエロバクター属、ブレビバクテリウム
属、ストレプトコツカス属、コリネバクテリウム
属、アルスロバクター属、セラチア属、シユード
モナス属、アセトバクター属、ストレプトミセス
属、サツカロマイセス属、ロドトラル属に属する
細菌、放射菌、酵母が好ましいものとして挙げら
れる。これ等の微生物菌体は、凍結乾燥や有機溶
媒処理を行つた処理菌体でもよく、又、培養され
た生菌体でもよい。生菌体は、固定化後、培地中
で増殖させることも出来る。
固定化される微生物菌体量は、その目的に応じ
適宜決めればよいが、余り過大であると、得られ
た固定化物からの菌体等の脱落が起こる為、一般
にフイブロイン蛋白量に対し、乾燥重量にして好
ましくは50重量%以下、特に好ましくは30重量%
以下である。
微生物菌体は、そのまま或いは懸濁液として前
記フイブロイン水溶液と混合するが、剪断力を作
用させることにより、微生物が損傷を受け易い
為、フイブロイン水溶液に剪断力を作用した後混
合する事が好ましい。
水溶液に流速勾配を与え、フイブロインに剪断
力を作用する手段としては種々の方法が考えられ
るが、例えば、ミキサー、ホモミキサー、プロペ
ラ等による撹拌や、細い管や、スリツトの間を通
過させること等があるが特に限定されるものでは
ない。しかし、過度に大きな剪断力を与えると短
時間にフイブロインが析出し、操作性が悪く、
又、非常に小さな剪断力では長い処理時間を必要
とする。水溶液に剪断力を作用した後、長時間放
置すると、ゲル化凝固又はフイブロインの析出が
起こり、成形が困難になつたり、不均一になつた
りする為、それ以前に水溶液の粘度が多少上昇し
た段階で成形工程に付することが肝要である。こ
の様にして調整した剪断力を作用し結晶を配向せ
しめたフイブロインと菌体とを溶解した水溶液は
成形工程に付されるが、成形は公知の方法から適
宜選定し菌体の使用目的に応じた形態に成形すれ
ばよい。
成形方法の一例として成膜法による場合を示す
と、通常、ガラス板、テフロン板、アクリル板等
の上に上記水溶液を流延し、温度2〜70℃下、好
ましくは10〜50℃下、放置又は通風することによ
り、乾燥固化し膜状に成形する。この際、剪断力
を作用させたフイブロイン−菌体混合水溶液をそ
のまま、或いは必要に応じてこれに増粘剤を加え
て増粘し、各種の形状を有する面上に塗布、乾燥
し、薄膜状に成形することも出来る。
本発明に係る固定化微生物は、特に膜状に成形
した場合剪断力を作用させなかつたときに得られ
る膜が殆どの場合、水中で半溶解し、形を留めな
いのに対し、完全な水不溶性膜となる。このこと
は本発明の大きな特長の1つである。
本発明の固定化微生物の製造法により常温及び
中性領域を含む温和な条件で実質的にフイブロイ
ンと酵素のみからなる微生物含有成形物を容易に
得ることが出来る。
その為、固定化による非生物菌体の損傷はな
く、生菌体の場合はその増殖能を保つたまま、又
処理菌体中の酵素活性も殆ど失われることなく固
定化される。
又一般に包括型の固定化の場合、その基質や培
地成分の透過性が問題となり、拡散律速となるが
フイブロイン膜の場合、この影響を受けにくい薄
膜とした場合に於いても可撓性で、十分な強度を
持つ特長を有する。この意味から膜厚は50μm以
下が好ましく、特に30μm以下では、低分子基質
に対する活性は、元の菌体と殆ど変わらない。
生菌体を固定化し、増殖させて用いる場合、固
定化物の内部では殆ど増殖が見られないことか
ら、菌体含量によつても異なるが、300μm以下
程度の膜厚とするのが効率的である。
更に、静止菌体の場合、固定化物からの菌体脱
落は見られず、安定な活性を示す。
(発明の効果)
本発明の方法により実質的に無害なフイブロイ
ンのみによる微生物菌体の固定化物が得られる
為、これを食品や医薬品等の製造に用うる事が出
来る。
又、センサー等にも有効に利用する事が可能で
ある。
以下、実施例にて本発明を具体的に説明する。
実施例 1
ブーレツト1Kgをマルセル石けん1重量%水溶
液30中に浸漬し、98℃で1時間撹拌混合し、実
質的にセリシンを完全に除き、十分に乾燥後、70
℃で乾燥した。次いで65重量%の塩化カルシウム
水溶液4Kgとエチルアルコール1.6Kgの入つたニ
ーダー中に前記精練ずみの生糸0.8Kgを投入し、
75〜80℃で45分間撹拌溶解した。得られた粘稠な
溶解液に80℃の温水3.2Kgを加え希釈し、再生セ
ルロース系中空繊維を用いた透析装置により透析
脱塩してフイブロイン水溶液を得た。該フイブロ
イン水溶液のフイブロイン濃度は5.5重量%であ
つた。
このフイブロイン水溶液を濃縮し、10.0重量%
とし、この200gをホモミキサー(特殊機化工業
社製Type4c)により4000rpmで撹拌した後、菌
体内にアルカリフオスフアターゼを有するエスシ
エリシア・コリ凍結乾燥菌体(シグマ社製)200
mgを混合し、5分間放置してからアクリル板上に
流延し、室温(20℃)で20時間乾燥成膜した。
得られた固定化菌体膜を、菌体中のアルカリフ
オスフアターゼ活性飯を指標として評価した。
活性測定法を以下に示す。
酵素活性測定法
エスシエリシア・コリ菌体含有膜(10mm×20
mm)をPH8.5−緩衝液2mlに浸漬し、これに、
0.01M−p−ニトロフエニルフオスフエート溶液
3mlを基質として加え、30℃で10分間振盪、反応
させた後、サンプリングし、これを等量の0.5N
−水酸化ナトリウム水溶液に加えて混合し、直し
ち410nmの吸収を測定し、生成p−ニトロフエ
ノールを定量する。繰り返し測定を行う場合は、
反応後の膜を取り出し、3回、緩衝液中に浸漬、
洗浄した後、次の測定に供給した。又、活性収率
は次式により算出した。
活性収率(%)=膜の発現活性/膜中の添加活性計算量
×100
得られた固定化菌体膜の膜性質と撹拌効果の関
係を第1表に示す。又撹拌を30秒行つた場合、得
た膜について、膜厚と活性の関係を第2表、繰り
返し測定結果を第3表に示す。
(Industrial Application Field) The present invention relates to a method for producing immobilized microorganisms. (Prior Art) In recent years, the production of useful compounds by utilizing the compound conversion and production abilities of microorganisms has become increasingly popular. Further, in order to make this into a form that can be used repeatedly and to easily separate the product from the microbial cells, research is actively being conducted on the use of immobilized microorganisms, and various methods are known. Traditionally, methods for immobilizing microorganisms have been made using synthetic polymers such as acrylamide polymers, hydroxyethyl methacrylate polymers, alginic acid, Entrapping immobilization with natural polymer gels such as carrageenan is said to be advantageous. However, in the case of methods using synthetic polymers such as polyacrylamide gel, microorganisms may die due to the toxicity of the monomer.
Deactivation of intracellular enzymes is likely to occur. In addition, initiators and sensitizers used in the photopolymerization crosslinking method may cause loss of bacterial cells, and when these immobilized microorganisms are used to manufacture foods, medicines, etc., products may be contaminated with these. There's a problem. Furthermore, many of these crosslinkable resins are brittle and have defects such as bending or shattering when molded into a film or the like. Immobilization using natural product polymer gels, i.e. calcium ion cross-linked gels of alginic acid and potassium ion gels of carrageenan, is a safe and mild method using natural products, but depending on the conditions of use, cross-linking may occur over time. There is a problem in that the cells are cut and peptized, resulting in leakage of bacterial cells, etc. Furthermore, since the products obtained by these methods become so-called diffusion-limited immobilized substances, it is advantageous to use them as thin films, but it is difficult to say that they have sufficient strength for this purpose. . (Problems to be Solved by the Invention) The present inventors have conducted intensive research into a method for immobilizing microorganisms that is efficient, has excellent stability, and has sufficient strength by improving the above-mentioned drawbacks. As a result, the present invention has been completed. The purpose of the present invention is to provide a stable method for immobilizing microorganisms that does not damage the microorganism cells, maintain high activity, or prevent them from dying, and that does not fall off over time. is to provide. Another object of the present invention is to have the above-mentioned features, and further have excellent physical properties such as membrane strength and flexibility, and
An object of the present invention is to provide a method for producing an immobilized microbial membrane that is less susceptible to diffusion-limiting effects. (Means for Solving the Problems) The above-mentioned purpose is to apply a shearing force to an aqueous solution in which fibroin whose crystal regions are oriented and microbial cells are dispersed, to precipitate the fibroin in the aqueous solution,
Alternatively, this can be achieved by a method for producing immobilized microorganisms, which is characterized by subjecting the aqueous solution to a molding step before solidification. In the method of the present invention, the aqueous solution containing microorganisms and fibroin can be prepared by various methods, but one preferred method is as follows. Silk raw materials such as raw silk, cocoon, raw silk scraps, kiki, bis, boulette, etc. are scoured to remove sericin in accordance with a conventional method, and then mixed with an aqueous solution of an alkali metal salt or alkaline earth metal salt capable of dissolving fibroin, or copper-ethylenediamine. An aqueous solution of fibroin is prepared in advance by dissolving it in an aqueous solution and desalting it by dialysis to adjust the concentration of fibroin to usually 1 to 20% by weight, preferably 5 to 15% by weight. The above alkali metal salts and alkaline earth metal salts include LiCl, LiBr, Nal, LiNO 3 , MgCl 2 ,
MgBr 2 , Mg(NO 3 ) 2 ZnCl 2 , Zn(NO 3 ) 2 etc. are used, but CaCl 2 or Ca(NO 3 ) 2 is used to keep the solubility and molecular weight of fibroin as high as possible.
It is preferable to use Further, the metal salt concentration is 5 to 80% by weight, preferably 20 to 70% by weight, particularly preferably 40 to 60% by weight. Further, in order to further improve the solubility, it is preferable to add alcohols such as methyl alcohol, ethyl alcohol, and propyl alcohol to the aqueous solution. The timing of addition is preferably before or during the dissolution of the silk, and the amount added is 20 to 60% by weight, preferably 25 to 50% by weight, based on the metal salt solution. The microorganisms to be immobilized in the present invention include yeast, bacteria, actinobacteria, etc., and examples include Achromobacter, Flavobacterium, Escherichia, Aerobacter, Brevibacterium, and Streptococcus. Preferred examples include bacteria belonging to the genus Corynebacterium, Arthrobacter, Serratia, Pseudomonas, Acetobacter, Streptomyces, Satucharomyces, and Rhodotoral, Actinobacteria, and yeast. These microbial cells may be treated cells subjected to freeze-drying or organic solvent treatment, or may be cultured living cells. After immobilization, viable bacterial cells can also be grown in a culture medium. The amount of microorganisms to be immobilized can be determined as appropriate depending on the purpose, but if it is too large, bacteria etc. will fall off from the obtained immobilized product. Preferably 50% by weight or less, particularly preferably 30% by weight
It is as follows. The microbial cells are mixed with the aqueous fibroin solution either as they are or as a suspension, but since the microorganisms are easily damaged by applying shearing force, it is preferable to apply shearing force to the aqueous fibroin solution before mixing. Various methods can be used to create a flow velocity gradient in the aqueous solution and apply shearing force to the fibroin. For example, stirring with a mixer, homomixer, propeller, etc., passing through a thin tube or slit, etc. There are, but there are no particular limitations. However, when excessively large shearing force is applied, fibroin precipitates in a short period of time, resulting in poor operability.
Also, very small shear forces require long processing times. If the aqueous solution is left to stand for a long time after applying a shearing force, gelation and coagulation or fibroin precipitation will occur, making molding difficult or uneven. It is important to subject it to the molding process. The aqueous solution in which the microbial cells and the fibroin, in which the crystals have been oriented by applying the shearing force adjusted in this manner, are dissolved is subjected to a molding process. It may be molded into a shape. An example of a forming method is a film forming method. Usually, the above aqueous solution is cast onto a glass plate, Teflon plate, acrylic plate, etc., and the temperature is 2 to 70°C, preferably 10 to 50°C. By leaving it to stand or ventilating it, it dries and solidifies and is formed into a film. At this time, the fibroin-bacteria mixed aqueous solution subjected to shearing force is applied as it is, or thickened by adding a thickener if necessary, and applied to surfaces of various shapes and dried to form a thin film. It can also be formed into In particular, when the immobilized microorganism according to the present invention is molded into a film, the film obtained when no shearing force is applied is semi-dissolved in water and does not retain its shape, whereas it is completely dissolved in water. It becomes an insoluble film. This is one of the major features of the present invention. By the method for producing immobilized microorganisms of the present invention, microorganism-containing molded articles consisting essentially of fibroin and enzymes can be easily obtained under mild conditions including room temperature and neutral regions. Therefore, non-living cells are not damaged by immobilization, and living cells are immobilized while maintaining their growth ability and with almost no loss of enzyme activity in the treated cells. In general, in the case of enveloping immobilization, the permeability of the substrate and culture medium components becomes a problem, and diffusion is rate-limiting, but in the case of fibroin membranes, even when made into a thin film that is not susceptible to this effect, it is flexible and It has the feature of sufficient strength. In this sense, the film thickness is preferably 50 μm or less, and in particular, if the film thickness is 30 μm or less, the activity toward low-molecular substrates is almost the same as that of the original bacterial cell. When living bacteria are immobilized and grown, almost no growth is observed inside the immobilized material, so it is efficient to use a film thickness of about 300 μm or less, although this varies depending on the bacterial content. be. Furthermore, in the case of stationary bacterial cells, no bacterial detachment from the immobilized material was observed, indicating stable activity. (Effects of the Invention) Since the method of the present invention provides a substantially harmless immobilized product of microbial cells made only of fibroin, this can be used in the production of foods, medicines, and the like. Moreover, it can be effectively used for sensors, etc. Hereinafter, the present invention will be specifically explained with reference to Examples. Example 1 1 kg of boulette was immersed in a 1% by weight aqueous solution of Marcel soap, stirred and mixed at 98°C for 1 hour to substantially completely remove sericin, and dried thoroughly.
Dry at °C. Next, 0.8 kg of the scoured raw silk was put into a kneader containing 4 kg of a 65% by weight calcium chloride aqueous solution and 1.6 kg of ethyl alcohol.
The mixture was stirred and dissolved at 75-80°C for 45 minutes. The resulting viscous solution was diluted with 3.2 kg of 80°C warm water, and desalted by dialysis using a dialysis device using regenerated cellulose hollow fibers to obtain a fibroin aqueous solution. The fibroin concentration of the fibroin aqueous solution was 5.5% by weight. Concentrate this fibroin aqueous solution to 10.0% by weight.
After stirring 200 g of this at 4000 rpm with a homomixer (Type 4c manufactured by Tokushu Kika Kogyo Co., Ltd.), freeze-dried S. coli cells (manufactured by Sigma) 200 g containing alkaline phosphatase in the bacterial cells were added.
mg were mixed, left to stand for 5 minutes, cast on an acrylic plate, and dried to form a film at room temperature (20°C) for 20 hours. The obtained immobilized cell membrane was evaluated using alkaline phosphatase activity in the cell as an index. The activity measurement method is shown below. Enzyme activity measurement method S. coli bacterial cell-containing membrane (10 mm x 20
mm) in 2 ml of PH8.5 buffer solution, and
Add 3 ml of 0.01M p-nitrophenyl phosphate solution as a substrate, shake at 30°C for 10 minutes, react, sample, and add an equal amount of 0.5N
- Add to aqueous sodium hydroxide solution, mix, and immediately measure absorption at 410 nm to quantify p-nitrophenol produced. When performing repeated measurements,
After the reaction, the membrane was taken out and immersed in the buffer solution three times.
After washing, it was supplied for the next measurement. In addition, the activity yield was calculated using the following formula. Activity yield (%) = expressed activity of the membrane/calculated amount of added activity in the membrane x 100 Table 1 shows the relationship between the membrane properties of the obtained immobilized bacterial cell membrane and the stirring effect. Further, when stirring was performed for 30 seconds, the relationship between film thickness and activity for the obtained film is shown in Table 2, and the results of repeated measurements are shown in Table 3.
【表】【table】
【表】【table】
【表】
これ等の結果より撹拌による不溶化効果が明瞭
に認められ、又、固定化物からの微生物菌体の脱
落はない。更に30μm以下の薄膜で、殆ど拡散抵
抗の影響はないにも拘らず、十分使用に耐える強
度を有する。
実施例 2
ロドトルラ・グルチニスIFO0559をモルト・エ
キス1%、酵母エキス0.1%、L−フエニルアラ
ニン0.1%、ポリペプトン1%を含む滅菌倍地1
中で、30℃、48時間振盪培養した後、遠心分離
集菌した。
得られた菌体を0.05M−トリス塩酸緩衝液/ト
ルエン(1容/5容)中に加え、50℃で5分間振
盪し、処理菌体を再び集菌し、同緩衝液で3度洗
浄した。
一方、実施例1と同様にして得たフイブロイン
水溶液を濃縮し濃度を9.5%とし、この200gを径
3cmの通常の撹拌羽根により回転数を変えて45分
間撹拌した後、この10gに得られた菌体1.8g
(乾燥重量330mg)を混合し、よく分散させた後ア
クリル板上に流延し、18℃相対湿度60%で24時間
乾燥成膜した。
撹拌回転数と、膜の性質、の関係を第4表に示
す。[Table] From these results, the insolubilization effect of stirring was clearly recognized, and there was no dropout of microbial cells from the immobilized material. Furthermore, it is a thin film of 30 μm or less, and has sufficient strength to withstand use, even though it has almost no effect on diffusion resistance. Example 2 Rhodotorula glutinis IFO0559 was prepared in sterile medium 1 containing 1% malt extract, 0.1% yeast extract, 0.1% L-phenylalanine, and 1% polypeptone.
After culturing with shaking at 30°C for 48 hours, the cells were collected by centrifugation. The obtained bacterial cells were added to 0.05M Tris-HCl buffer/toluene (1 volume/5 volumes), shaken at 50°C for 5 minutes, and the treated bacterial cells were collected again and washed 3 times with the same buffer. did. On the other hand, the aqueous fibroin solution obtained in the same manner as in Example 1 was concentrated to a concentration of 9.5%, and 200 g of this was stirred for 45 minutes at varying rotation speeds using a regular stirring blade with a diameter of 3 cm. 1.8g of bacterial cells
(dry weight 330 mg) were mixed and well dispersed, then cast onto an acrylic plate and dried to form a film at 18° C. and 60% relative humidity for 24 hours. Table 4 shows the relationship between the stirring rotation speed and the properties of the membrane.
【表】
上記の方法で2000rpmで撹拌して得た膜厚50μ
mの固定化膜片(10mm×20mm)3枚を桂皮酸50m
M濃度のアンモニア−塩酸緩衝液(6.5M、PH10)
3mlに浸漬し、30℃で20時間振盪したところ、桂
皮酸の65%がL−フエニルアラニンに転換した。
但し、反応は、サンプリング液を100倍希釈し、
290nmの吸光度で桂皮酸の減少により追跡し、
等速電気泳動法によりL−フエニルアラニンの同
定を行つた。
実施例 3
サツカロミセス・セレビジエIFO−0234をモル
トエキス0.3%、酵母エキス0.3%、ペプトン0.5
%、グルコース1%を含むPH5.0の減菌培地500ml
中で30℃、1日振盪培養した後、遠心分離で集菌
し、減菌生理食塩水で3回洗浄した。
実施例1と同様に、濃度15.0重量%のフイブロ
イン水溶液、150gをホモミキサーを用いて
2500rpmで時間を変えて撹拌した後、この12.5g
に上記で得た湿潤菌体3g(乾燥重量0.75g)を
混合し、アルキル板上に流延した。22℃で20時間
乾燥成膜した。
膜厚120μmとした特、ホモミキサー撹拌時間
が30秒、60秒の場合は、共に水不溶性の固定化膜
を得ることが出来が、撹拌しない場合は、水中で
崩壊した。又、150秒撹拌すると、析出が起こり、
成膜不能であつた。
撹拌時間を60秒として得た固定化膜(1cm×2
cm)5枚を滅菌した10%グルコース水溶液10mlに
入れ、30℃で1日静置し、生成エタノール量をガ
スクロマトグラフイー測定した結果、水溶液中に
4.3重量%のエタノールが認められた。
実施例 4
実施例3で得たサツカロミセス・セレビジエ固
定化膜を酵母エキス0.15%、NH4Cl0.25%、
HK2PO40.55%、MgSO4・7H2O0.025%、
CaCl20.001%、クエン酸0.3%、NaCl0.25%.グ
ルコース10%を含むPH5.0の滅菌培地中に浸漬し、
30℃で1日振盪した。
この固定化膜(1cm×2cm)5枚をNaCl0.9%
を含む10%グルコース水溶液10mlに入れ、30℃で
1日静置し、生成エタノール量を測定した。
膜を滅菌水で生成した後、新たなグルコース水
溶液10mlに入れる方法で繰り返し実験を行つた。
結果を第5表に示す。菌体の脱落は認められなか
つた。[Table] Film thickness 50μ obtained by stirring at 2000rpm using the above method
3 immobilized membrane pieces (10 mm x 20 mm) with 50 m of cinnamic acid
M concentration ammonia-hydrochloric acid buffer (6.5M, PH10)
When the solution was immersed in 3 ml of water and shaken at 30°C for 20 hours, 65% of the cinnamic acid was converted to L-phenylalanine.
However, for the reaction, dilute the sampling solution 100 times,
tracked by the decrease in cinnamic acid at absorbance at 290 nm,
L-phenylalanine was identified by isotachophoresis. Example 3 Satucharomyces cerevisiae IFO-0234 was mixed with 0.3% malt extract, 0.3% yeast extract, and 0.5 peptone.
%, 500 ml of sterile medium with pH 5.0 containing 1% glucose
After culturing with shaking at 30°C for one day, the cells were collected by centrifugation and washed three times with sterile physiological saline. As in Example 1, 150 g of a fibroin aqueous solution with a concentration of 15.0% by weight was added using a homomixer.
After stirring at 2500rpm for different times, this 12.5g
3 g of the wet bacterial cells obtained above (dry weight 0.75 g) were mixed with the mixture and cast onto an alkyl plate. A dry film was formed at 22°C for 20 hours. In particular, when the film thickness was 120 μm and the homomixer stirring time was 30 seconds or 60 seconds, a water-insoluble immobilized film could be obtained, but when stirring was not performed, it collapsed in water. Also, when stirred for 150 seconds, precipitation occurs,
It was impossible to form a film. Immobilized membrane (1 cm x 2) obtained with stirring time of 60 seconds
cm) were placed in 10 ml of a sterilized 10% glucose aqueous solution and allowed to stand at 30°C for one day, and the amount of ethanol produced was measured using gas chromatography.
4.3% by weight of ethanol was observed. Example 4 The Saccharomyces cerevisiae immobilized membrane obtained in Example 3 was mixed with yeast extract 0.15%, NH 4 Cl 0.25%,
HK2PO4 0.55 %, MgSO4・7H2O0.025 %,
CaCl 2 0.001%, citric acid 0.3%, NaCl 0.25%. immersed in sterile medium of PH5.0 containing 10% glucose;
It was shaken at 30°C for 1 day. Five of these immobilized membranes (1 cm x 2 cm) were mixed with 0.9% NaCl.
The sample was placed in 10 ml of a 10% glucose aqueous solution containing 10% glucose, and left to stand at 30°C for 1 day, and the amount of ethanol produced was measured. The experiment was repeated by forming the membrane in sterile water and then placing it in 10 ml of fresh glucose aqueous solution.
The results are shown in Table 5. No bacterial cells were observed to fall off.
Claims (1)
ブロインと、微生物菌体とを分散した水溶液を、
水溶液中へのフイブロインの析出或いは水溶液の
凝固が起こる前に、成形工程に付すことを特徴と
する固定化微生物の製造法。 2 微生物菌体が生菌体である特許請求の範囲第
1項に記載の固定化微生物の製造方法。 3 成型工程がフイルム成形である特許請求の範
囲第1項に記載の固定化微生物の製造方法。 4 フイルムが膜厚300μm以下のものである特
許請求の範囲第3項に記載の固定化微生物の製造
方法。 5 フイルムが膜厚50μm以下のものである特許
請求の範囲第3項に記載の固定化微生物の製造方
法。[Claims] 1. An aqueous solution in which fibroin whose crystal regions have been oriented by shearing force and microorganism cells are dispersed,
1. A method for producing immobilized microorganisms, which comprises subjecting them to a molding step before precipitation of fibroin into an aqueous solution or coagulation of the aqueous solution occurs. 2. The method for producing an immobilized microorganism according to claim 1, wherein the microorganism is a living microorganism. 3. The method for producing an immobilized microorganism according to claim 1, wherein the molding step is film molding. 4. The method for producing immobilized microorganisms according to claim 3, wherein the film has a thickness of 300 μm or less. 5. The method for producing an immobilized microorganism according to claim 3, wherein the film has a thickness of 50 μm or less.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9210585A JPS61249391A (en) | 1985-04-27 | 1985-04-27 | Production of immobilized microorganism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9210585A JPS61249391A (en) | 1985-04-27 | 1985-04-27 | Production of immobilized microorganism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61249391A JPS61249391A (en) | 1986-11-06 |
| JPH0456592B2 true JPH0456592B2 (en) | 1992-09-08 |
Family
ID=14045157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9210585A Granted JPS61249391A (en) | 1985-04-27 | 1985-04-27 | Production of immobilized microorganism |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61249391A (en) |
-
1985
- 1985-04-27 JP JP9210585A patent/JPS61249391A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61249391A (en) | 1986-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5089272A (en) | Process for producing capsules having a permeability-controllable membrane | |
| US4774093A (en) | Polysaccharide compositions, preparation and uses | |
| Mathur et al. | Chitin and chitosan, versatile polysaccharides from marine animals | |
| JPS63240780A (en) | Freeze dry culture of pseudomonas atcc 31461 | |
| JPH0694518B2 (en) | Method for producing silk fibroin porous body | |
| KR910002854B1 (en) | Enzyme Fixation Method | |
| DE2219063C3 (en) | Process for the production of an enzymatically active membrane, membrane produced by this process and its use for enzyme-catalyzed substrate conversions | |
| JPS59113889A (en) | Preparation of immobilized enzyme or immobilized microbial cell | |
| DE2407961B2 (en) | ENZYMATICALLY ACTIVE MEMBRANE, PROCESS FOR THEIR MANUFACTURING AND USE | |
| JPH03259928A (en) | Production of highly polymeric gelatin | |
| JPH0456592B2 (en) | ||
| US5093253A (en) | Method for microbial immobilization by entrapment in gellan gum | |
| Berger et al. | Stable ionotropic gel for cell immobilization using high molecular weight pectic acid | |
| JPS5974984A (en) | Preparation of immobilized enzyme or microorganism | |
| DD294729A5 (en) | PROCESS FOR THE PRODUCTION OF IMMOBILISATES WITH BIOLOGICALLY ACTIVE, MACROMOLECULAR COMPOUNDS | |
| JPH0456593B2 (en) | ||
| CA1319632C (en) | Method for microbial immobilization | |
| JPS58155092A (en) | Cell catalyst and its manufacturing method | |
| Quirós et al. | The evolution of the structure of calcium alginate beads and cell leakage during protease production | |
| JP3055963B2 (en) | Polymer gel for biocatalyst-immobilized moldings | |
| SU1634715A1 (en) | Method for producing immobilized cells exhibiting glucosoisomerase activity | |
| JP2729448B2 (en) | Immobilized enzyme membrane | |
| JPH0466094A (en) | Enzymatic decomposition of starch-containing material and production of oligosaccharide | |
| JPS60227680A (en) | Production of immobilized enzyme | |
| Willetts | Diol production by Aeromonas hydrophila: Comparison of different immobilization techniques |